<VariationArchive VariationID="44738" VariationName="NM_004004.6(GJB2):c.31_68del (p.Gly11fs)" VariationType="Deletion" Accession="VCV000044738" Version="31" RecordType="classified" NumberOfSubmissions="10" NumberOfSubmitters="9" DateLastUpdated="2024-07-29" DateCreated="2015-01-30" MostRecentSubmission="2024-07-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="53905" VariationID="44738">
      <GeneList>
        <Gene Symbol="GJB2" FullName="gap junction protein beta 2" GeneID="2706" HGNC_ID="HGNC:4284" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>13q12.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="20187470" stop="20192938" display_start="20187470" display_stop="20192938" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="20761601" stop="20767113" display_start="20761601" display_stop="20767113" Strand="-" />
          </Location>
          <OMIM>121011</OMIM>
          <Haploinsufficiency last_evaluated="2012-05-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GJB2">Dosage sensitivity unlikely</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-05-10" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GJB2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_004004.6(GJB2):c.31_68del (p.Gly11fs)</Name>
      <CanonicalSPDI>NC_000013.11:20189513:ATCTTTCCAATGCTGGTGGAGTGTTTGTTCACACCCCC:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>13q12.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="13" Accession="NC_000013.11" start="20189514" stop="20189551" display_start="20189514" display_stop="20189551" variantLength="38" positionVCF="20189513" referenceAlleleVCF="GATCTTTCCAATGCTGGTGGAGTGTTTGTTCACACCCCC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="13" Accession="NC_000013.10" start="20763653" stop="20763690" display_start="20763653" display_stop="20763690" variantLength="38" positionVCF="20763652" referenceAlleleVCF="GATCTTTCCAATGCTGGTGGAGTGTTTGTTCACACCCCC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>G11fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.10" sequenceAccession="NC_000013" sequenceVersion="10" change="g.20763653_20763690del" Assembly="GRCh37">
            <Expression>NC_000013.10:g.20763653_20763690del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000013.11" sequenceAccession="NC_000013" sequenceVersion="11" change="g.20189514_20189551del" Assembly="GRCh38">
            <Expression>NC_000013.11:g.20189514_20189551del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008358.1" sequenceAccession="NG_008358" sequenceVersion="1" change="g.8425_8462del">
            <Expression>NG_008358.1:g.8425_8462del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004004.6" sequenceAccession="NM_004004" sequenceVersion="6" change="c.31_68del" MANESelect="true">
            <Expression>NM_004004.6:c.31_68del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003995.2" sequenceAccession="NP_003995" sequenceVersion="2" change="p.Gly11fs">
            <Expression>NP_003995.2:p.Gly11fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1350" sequenceAccession="LRG_1350">
            <Expression>LRG_1350:g.8425_8462del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1350t1" sequenceAccession="LRG_1350t1">
            <Expression>LRG_1350t1:c.31_68del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1350p1" sequenceAccession="LRG_1350p1" change="p.Gly11fs">
            <Expression>LRG_1350p1:p.Gly11fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA261644" DB="ClinGen" />
        <XRef Type="rs" ID="397516873" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00001" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00002" Source="The Genome Aggregation Database (gnomAD), exomes" />
        <AlleleFrequency Value="0.00002" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00003" Source="Exome Aggregation Consortium (ExAC)" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004004.6(GJB2):c.31_68del (p.Gly11fs) AND Rare genetic deafness" Accession="RCV000037837" Version="6">
        <ClassifiedConditionList TraitSetID="40993">
          <ClassifiedCondition DB="MedGen" ID="C5680250">Rare genetic deafness</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2012-04-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004004.6(GJB2):c.31_68del (p.Gly11fs) AND Autosomal recessive nonsyndromic hearing loss 1A" Accession="RCV000409896" Version="3">
        <ClassifiedConditionList TraitSetID="5610">
          <ClassifiedCondition DB="MedGen" ID="C2673759">Autosomal recessive nonsyndromic hearing loss 1A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2020-07-24" SubmissionCount="2">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004004.6(GJB2):c.31_68del (p.Gly11fs) AND Autosomal dominant nonsyndromic hearing loss 3A" Accession="RCV000411009" Version="3">
        <ClassifiedConditionList TraitSetID="5611">
          <ClassifiedCondition DB="MedGen" ID="C2675750">Autosomal dominant nonsyndromic hearing loss 3A</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2016-03-14" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004004.6(GJB2):c.31_68del (p.Gly11fs) AND not provided" Accession="RCV000517627" Version="23">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-26" SubmissionCount="4">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004004.6(GJB2):c.31_68del (p.Gly11fs) AND Nonsyndromic genetic hearing loss" Accession="RCV001527052" Version="2">
        <ClassifiedConditionList TraitSetID="9568">
          <ClassifiedCondition DB="MedGen" ID="C5680182">Nonsyndromic genetic hearing loss</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-06-09" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004004.6(GJB2):c.31_68del (p.Gly11fs) AND GJB2-related disorder" Accession="RCV004534806" Version="1">
        <ClassifiedConditionList TraitSetID="47297">
          <ClassifiedCondition>GJB2-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-05" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-26" NumberOfSubmissions="10" NumberOfSubmitters="9" DateCreated="2015-01-30" MostRecentSubmission="2024-07-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12189487</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16380907</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21465647</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23141775</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25214170</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9336442</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9529365</ID>
        </Citation>
        <DescriptionHistory Dated="2017-01-05">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9568" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9544" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Nonsyndromic hearing loss and deafness</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nonsyndromic genetic deafness</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Nonsyndromic genetic hearing loss</ElementValue>
                <XRef ID="MONDO:0019497" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Non-syndromic genetic deafness</ElementValue>
                <XRef ID="87884" DB="Orphanet" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19091" />
                <XRef ID="19091" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6410" />
                <XRef ID="6410" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="general" Abbrev="ACMG, 2002">
                <ID Source="pmc">3110944</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2023">
                <URL>https://www.nice.org.uk/guidance/ng98</URL>
                <CitationText>UK NICE Guideline (NG98), Hearing loss in adults: assessment and management, 2023</CitationText>
              </Citation>
              <XRef ID="87884" DB="Orphanet" />
              <XRef ID="C5680182" DB="MedGen" />
              <XRef ID="MONDO:0019497" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="40993" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="38576" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Rare genetic deafness</ElementValue>
                <XRef ID="96210" DB="Orphanet" />
              </Name>
              <XRef ID="96210" DB="Orphanet" />
              <XRef ID="C5680250" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5611" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4900" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Deafness, autosomal dominant 3a</ElementValue>
                <XRef ID="Deafness%2C+autosomal+dominant+3a/8144" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal dominant nonsyndromic hearing loss 3A</ElementValue>
                <XRef ID="MONDO:0011103" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">DFNA3A</ElementValue>
                <XRef Type="MIM" ID="601544" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Nonsyndromic hearing loss and deafness, DFNA3 is characterized by pre- or postlingual mild-to-profound progressive high-frequency sensorineural hearing impairment. Affected individuals have no other associated medical findings.</Attribute>
                <XRef ID="NBK1536" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9933" />
                <XRef ID="9933" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301607</ID>
                <ID Source="BookShelf">NBK1434</ID>
              </Citation>
              <XRef ID="90635" DB="Orphanet" />
              <XRef ID="C2675750" DB="MedGen" />
              <XRef ID="MONDO:0011103" DB="MONDO" />
              <XRef Type="MIM" ID="601544" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="5610" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="946" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GJB6-Related DFNB 1 Nonsyndromic Hearing Loss and Deafness</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Deafness, autosomal recessive 1A</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">DFNB 1 Nonsyndromic Hearing Loss and Deafness</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal recessive nonsyndromic hearing loss 1A</ElementValue>
                <XRef ID="MONDO:0009076" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Connexin 26 deafness</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Deafness nonsyndromic, Connexin 26 linked</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nonsyndromic Hearing Loss and Deafness, DFNB1</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">DFNB1A</ElementValue>
                <XRef Type="MIM" ID="220290" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">DFNB1</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">GJB2-related deafness</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Nonsyndromic hearing loss and deafness (DFNB1) is characterized by congenital non-progressive mild-to-profound sensorineural hearing impairment. No other associated medical findings are present.</Attribute>
                <XRef ID="NBK1272" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="1697" />
                <XRef ID="1697" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301449</ID>
                <ID Source="BookShelf">NBK1272</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301607</ID>
                <ID Source="BookShelf">NBK1434</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2002">
                <ID Source="pmc">3110944</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2009">
                <URL>https://www.nice.org.uk/guidance/ta166</URL>
                <CitationText>National Institute for Health and Clinical Excellence, Cochlear implants for children and adults with severe to profound deafness, 2009 [See 2019 Update, TA566]</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2019">
                <URL>https://www.nice.org.uk/guidance/TA566</URL>
                <CitationText>Cochlear implants for children and adults with severe to profound deafness (2019 Update)</CitationText>
              </Citation>
              <XRef ID="90636" DB="Orphanet" />
              <XRef ID="C2673759" DB="MedGen" />
              <XRef ID="MONDO:0009076" DB="MONDO" />
              <XRef Type="MIM" ID="220290" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="47297" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="41705" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">GJB2-related condition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">GJB2-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">GJB2-Related Disorders</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1197165" SubmissionDate="2017-08-17" DateLastUpdated="2017-12-19" DateCreated="2017-12-19">
        <ClinVarSubmissionID localKey="NM_004004.5:c.31_68del|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000613511" DateUpdated="2017-12-19" DateCreated="2017-12-19" Type="SCV" Version="1" SubmitterName="Athena Diagnostics" OrgID="1012" OrganizationCategory="laboratory" OrgAbbreviation="ADX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-03-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9529365</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12189487</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25214170</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9336442</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Athena Diagnostics Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">26467025</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004004.5:c.31_68del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB2963629</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4084995" SubmissionDate="2022-02-09" DateLastUpdated="2022-02-13" DateCreated="2022-02-13">
        <ClinVarSubmissionID localKey="NM_004004.6:c.31_68del|Autosomal recessive deafness type 1A" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002086067" DateUpdated="2022-02-13" DateCreated="2022-02-13" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-07-24">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004004.6:c.31_68del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Autosomal recessive deafness type 1A</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10993736</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="102699" SubmissionDate="2019-03-21" DateLastUpdated="2015-01-30" DateCreated="2013-05-03">
        <ClinVarSubmissionID localKey="11612938|Orphanet:ORPHA96210" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000061499" DateUpdated="2015-01-30" DateCreated="2013-05-03" Type="SCV" Version="5" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-04-17">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9336442</ID>
          </Citation>
          <Comment>The Gly11fs variant in GJB2 has been reported in one individual with hearing los s (Denoyelle 1997). This frameshift variant is predicted to alter the protein?s amino acid sequence beginning at position 11 and lead to a premature termination codon 24 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. In summary, this variant meets our criteria to be classified as pathogenic (http://pcpgm.partners.org/LMM).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_004004.5:EXON 2</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NM_004004.5:c.31_68del</Name>
            <Name>p.Gly11fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000013.10:g.20763653_20763690del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA96210" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5348977</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="951291" SubmissionDate="2019-08-05" DateLastUpdated="2017-01-06" DateCreated="2017-01-06">
        <ClinVarSubmissionID localKey="126169|OMIM:220290" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000487541" DateUpdated="2017-01-06" DateCreated="2017-01-06" Type="SCV" Version="2" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-03-14">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16380907</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21465647</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="13" alternateAllele="G" referenceAllele="GATCTTTCCAATGCTGGTGGAGTGTTTGTTCACACCCCC" start="20763652" stop="20763690" variantLength="39" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="220290" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6133108</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2305914" SubmissionDate="2019-10-15" DateLastUpdated="2020-03-16" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="GDX:1592543|Not Provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001167921" DateUpdated="2020-03-16" DateCreated="2020-03-16" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-06-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.31_68del38 variant in the GJB2 gene has been reported previously in association with hearing loss (Snoeckx et al., 2005; Dodson et al., 2011; Beck et al., 2014). The deletion causes a frameshift starting with codon Glycine 11, changes this amino acid to a Leucine residue and creates a premature Stop codon at position 24 of the new reading frame, denoted p.Gly11LeufsX24. This variant is predicted to cause loss of normal protein function through protein truncation. The variant is observed in 5/110262 (0.0045%) alleles from individuals of European background in large population cohorts (Lek et al., 2016). In summary, we consider this variant to be pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification (06012015)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/dhtz9flo/genedx_interprules_final_061215.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004004.5:c.31_68del38</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6425168</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3418285" SubmissionDate="2021-06-17" DateLastUpdated="2021-06-23" DateCreated="2021-06-23">
        <ClinVarSubmissionID localKey="NM_004004.5:c.31_68del38|MedGen:CN043648" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001737887" DateUpdated="2021-06-23" DateCreated="2021-06-23" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-06-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">21465647</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12189487</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9336442</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25214170</ID>
          </Citation>
          <Comment>Variant summary: GJB2 c.31_68del38 (p.Gly11LeufsX24) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 2e-05 in 250064 control chromosomes. c.31_68del38 has been reported in the literature in multiple individuals affected with Non-Syndromic Hearing Loss (e.g. Denoyelle_1997, Janecke_2002, Dodson_2011, Beck_2015). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Three other clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories cited the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004004.5:c.31_68del38</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN043648" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9873253</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="951292" SubmissionDate="2016-11-23" DateLastUpdated="2022-12-24" DateCreated="2017-01-06">
        <ClinVarSubmissionID localKey="126169|OMIM:601544" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000487542" DateUpdated="2022-12-24" DateCreated="2017-01-06" Type="SCV" Version="2" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-03-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">16380907</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21465647</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015)</Attribute>
          <Citation Type="general">
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rb7nm21v/ar_xl2015criteria.pdf</URL>
            <CitationText>mdi-5618_320494_Counsyl Autosomal and X-linked Recessive Disease Classification criteria (2015).pdf</CitationText>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004004.5:c.31_68del38</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="601544" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Counsyl2016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4125557" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="7888682|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002110910" DateUpdated="2024-02-20" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9336442</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12189487</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16380907</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21465647</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25214170</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23141775</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Gly11Leufs*24) in the GJB2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 216 amino acid(s) of the GJB2 protein. This variant is present in population databases (rs397516873, gnomAD 0.005%). This premature translational stop signal has been observed in individual(s) with autosomal recessive non-syndromic deafness (PMID: 9336442, 12189487, 16380907, 21465647, 25214170). This variant is also known as 31del38. ClinVar contains an entry for this variant (Variation ID: 44738). This variant disrupts a region of the GJB2 protein in which other variant(s) (p.Leu213*) have been determined to be pathogenic (PMID: 23141775). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000013.10:g.20763653_20763690del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8801087" SubmissionDate="2024-03-08" DateLastUpdated="2024-03-16" DateCreated="2024-03-16">
        <ClinVarSubmissionID localKey="3574357|GJB2-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004724624" DateUpdated="2024-03-16" DateCreated="2024-03-16" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The GJB2 c.31_68del38 variant is predicted to result in a frameshift and premature protein termination (p.Gly11Leufs*24). This variant was reported in several individuals with autosomal recessive deafness (Denoyelle et al. 1997. PubMed ID: 9336442; Dodson et al. 2011. PubMed ID: 21465647; Tang et al. 2006. PubMed ID: 17041943; and several other reports). This variant is reported in 0.0045% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Frameshift variants in GJB2 are expected to be pathogenic and this variant has been consistently classified as pathogenic or likely pathogenic in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/44738/). This variant is interpreted as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004004.5:c.31_68del38</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">GJB2-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14299258</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3849701" SubmissionDate="2024-07-04" DateLastUpdated="2024-07-15" DateCreated="2021-10-08">
        <ClinVarSubmissionID localKey="110506|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001961392" DateUpdated="2024-07-15" DateCreated="2021-10-08" Type="SCV" Version="17" SubmitterName="CeGaT Center for Human Genetics Tuebingen" OrgID="505870" OrganizationCategory="laboratory" OrgAbbreviation="CHGT" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-09-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">CeGaT Center For Human Genetics Tuebingen Variant Classification Criteria Version 2</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/0ynenhfo/cegat_center_for_human_genetics_tuebingen_-_variant_classification_criteria_-_version_2.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GJB2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="13" alternateAllele="G" referenceAllele="GATCTTTCCAATGCTGGTGGAGTGTTTGTTCACACCCCC" start="20763652" stop="20763690" variantLength="39" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>2021-10</SubmissionName>
          <SubmissionName>2022-01-corrected</SubmissionName>
          <SubmissionName>2022-04</SubmissionName>
          <SubmissionName>2022-07</SubmissionName>
          <SubmissionName>2022-08</SubmissionName>
          <SubmissionName>2022-10.3</SubmissionName>
          <SubmissionName>2023-01</SubmissionName>
          <SubmissionName>2023-04</SubmissionName>
          <SubmissionName>2023-09-add-ACMG-details</SubmissionName>
          <SubmissionName>2023-10</SubmissionName>
          <SubmissionName>2024-04</SubmissionName>
          <SubmissionName>SUB13641132</SubmissionName>
          <SubmissionName>SUB13985080</SubmissionName>
          <SubmissionName>SUB14102099</SubmissionName>
          <SubmissionName>SUB14290090</SubmissionName>
          <SubmissionName>SUB14426581</SubmissionName>
          <SubmissionName>SUB14513473</SubmissionName>
          <SubmissionName>SUB14584463</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3849701" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="951291" TraitType="Disease" MappingType="XRef" MappingValue="220290" MappingRef="OMIM">
        <MedGen CUI="C2673759" Name="Autosomal recessive nonsyndromic hearing loss 1A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="951292" TraitType="Disease" MappingType="XRef" MappingValue="601544" MappingRef="OMIM">
        <MedGen CUI="C2675750" Name="Autosomal dominant nonsyndromic hearing loss 3A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8801087" TraitType="Disease" MappingType="Name" MappingValue="GJB2-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="GJB2-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3418285" TraitType="Disease" MappingType="XRef" MappingValue="CN043648" MappingRef="MedGen">
        <MedGen CUI="C5680182" Name="Nonsyndromic genetic hearing loss" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1197165" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2305914" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4084995" TraitType="Disease" MappingType="Name" MappingValue="Autosomal recessive deafness type 1A" MappingRef="Preferred">
        <MedGen CUI="C2673759" Name="Autosomal recessive nonsyndromic hearing loss 1A" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4125557" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="102699" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA96210" MappingRef="Orphanet">
        <MedGen CUI="C5680250" Name="Rare genetic deafness" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

